Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generic vs Innovator Escitalopram in Chinese Patients with Depression
NCT00866593Phase 3Completed
- Sponsor
- Shanghai Mental Health Center
- Start
- Mar 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escitalopram in major depressive disorder (MDD), sponsored by Shanghai Mental Health Center. Started Mar 2009; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00866593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866593.